Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Therapeutic Advances in Medical Oncology
|
November 25, 2021
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
Mark A Socinski, Cornelius F Waller, Tazeen Idris, et al.
Translational Stroke Research
|
April 23, 2024
Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep
Bart R Thomson, Nina Schwendinger, Katrin Beckmann, et al.
Expert Opinion on Biological Therapy
|
May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
Susan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Annals of Hematology
|
March 3, 2019
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia
Cornelius F Waller, Gopinath M Ranganna, Eduardo J Pennella, et al.
JAMA Ophthalmology
|
September 12, 2024
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial
Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, et al.
JFMS Open Reports
|
September 22, 2025
Navigating neurological re-emergence in feline infectious peritonitis: challenges and insights from GS-441524 and remdesivir treatment
Celia C de Witt Curtius, Maxime Rodary, Regina Hofmann-Lehmann, et al.
Journal of Veterinary Internal Medicine
|
September 20, 2023
Relationship between magnetic resonance imaging findings and histological grade in spinal peripheral nerve sheath tumors in dogs
Simona Morabito, Swan Specchi, Pamela Di Donato, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Therapeutic Advances in Medical Oncology
|
November 25, 2021
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
Mark A Socinski, Cornelius F Waller, Tazeen Idris, et al.
Translational Stroke Research
|
April 23, 2024
Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep
Bart R Thomson, Nina Schwendinger, Katrin Beckmann, et al.
Expert Opinion on Biological Therapy
|
May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trial
Susan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Annals of Hematology
|
March 3, 2019
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia
Cornelius F Waller, Gopinath M Ranganna, Eduardo J Pennella, et al.
JAMA Ophthalmology
|
September 12, 2024
Aflibercept Biosimilar MYL-1701P vs Reference Aflibercept in Diabetic Macular Edema: The INSIGHT Randomized Clinical Trial
Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, et al.
JFMS Open Reports
|
September 22, 2025
Navigating neurological re-emergence in feline infectious peritonitis: challenges and insights from GS-441524 and remdesivir treatment
Celia C de Witt Curtius, Maxime Rodary, Regina Hofmann-Lehmann, et al.
Journal of Veterinary Internal Medicine
|
September 20, 2023
Relationship between magnetic resonance imaging findings and histological grade in spinal peripheral nerve sheath tumors in dogs
Simona Morabito, Swan Specchi, Pamela Di Donato, et al.
Page
of 5